ClinicalTrials.Veeva

Menu

Pilot-RCT With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder (Pilot-RCT ASD)

A

Aditi Chadha

Status and phase

Completed
Phase 4

Conditions

Autism Spectrum Disorder (ASD)

Treatments

Drug: Placebo
Drug: Homoeopathic medicines
Behavioral: THERAPY

Study type

Interventional

Funder types

Other

Identifiers

NCT07054697
20172024

Details and patient eligibility

About

This study looked at whether homeopathic treatment could help children with Autism Spectrum Disorder (ASD) when used alongside regular therapies like speech and occupational therapy. Over seven years, children between the ages of 2 and 12 were divided into two groups (through computer generated list). One group received individualized homeopathic medicines, and the other received a look-alike placebo (with no active ingredients). Meanwhile, both the groups continued with their regular therapies.

Researchers used various tools and parent questionnaires to track the children's progress in areas like communication, behavior, social skills, daily functioning, toilet training and sensory skills. They found that the children who received homeopathic treatment showed more improvement in these areas compared to those who just received only speech / occupational therapies.

Enrollment

54 patients

Sex

All

Ages

3 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A confirmed diagnosis of Autism Spectrum Disorder (ABC score ≥ 67)
  • Age range of 2 to 12 years

Exclusion criteria

  • Children with other significant comorbid psychiatric conditions that could confound the results. [eg. a brain injury; fragile X syndrome or other syndromes resulting from known genetic defects or inherited metabolic diseases; other diagnosed conditions involving impairments in social and communication abilities, such as intellectual disability without ASD, schizophrenia, language disorders and social communication disorder]
  • Children with irregular follow ups.
  • Children with poor medical compliance.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

54 participants in 2 patient groups, including a placebo group

HOMOEOPATHIC GROUP
Experimental group
Treatment:
Behavioral: THERAPY
Drug: Homoeopathic medicines
CONTROL GROUP
Placebo Comparator group
Description:
SACCHARUM LACTIS
Treatment:
Behavioral: THERAPY
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems